Search

1. Unsupported price increase report: 2020 assessment

Author(s):

Rind, David M., author
Agboola, Foluso, author
Chapman, Richard, author
Borrelli, Eric, author
McKenna, Avery, author
Pearson, Steven D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 12, 2021

Subject(s):

Drug Costs -- statistics & numerical data
Health Expenditures -- statistics & numerical data
United States

2. Special assessment of outpatient treatments for COVID-19: nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update

Author(s):

Whittington, Melanie D., author
Campbell, Jonathan D., author
Richardson, Marina, author
Nhan, Emily, author
McKenna, Avery, author
Agboola, Foluso, author
Pearson, Steven D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2022

Subject(s):

Ambulatory Care -- economics
Antiviral Agents -- economics
COVID-19 Drug Treatment
Drug Combinations
Drug Costs
Lactams
Leucine
Nitriles
Proline
Ritonavir
United States

3. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value : final evidence report

Author(s):

Atlas, Steven J., author
Fox, Grace E., author
Agboola, Foluso, author
Campbell, Jonathan D., author
Pearson, Steven D., author
Rind, David M., author
Brouwer, Elizabeth, author
Carlson, Josh, author
Chen, Yilin, (Of University of Washington), author
Hansen, Ryan N., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 27, 2023

Subject(s):

Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic
Janus Kinase Inhibitors -- therapeutic use
United States

4. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

Author(s):

Lin, Grace A., author
Whittington, Melanie D., author
Nikitin, Dmitriy, author
Agboola, Foluso, author
McKenna, Avery, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Campbell, Jonathan D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 21, 2023

Subject(s):

Antibodies, Monoclonal -- therapeutic use
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Treatment Outcome
Administration, Oral
United States

5. Lecanemab for early Alzheimer’s disease: final evidence report

Author(s):

Lin, Grace A., author
Whittington, Melanie D., author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Agboola, Foluso, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Rind, David, (Of Institute for Clinical and Economic Review), author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 17, 2023

Subject(s):

Alzheimer Disease -- drug therapy
Antibodies, Monoclonal, Humanized
United States

6. Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report

Author(s):

Tice, Jeffrey A., author
Chu, Janet N., author
Moradi, Ashton, author
Herce-Hagiwara, Belen, author
Fahim, Shahariar Mohammed, author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Walton, Surrey M., author
Sarker, Jyotirmoy, author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 22, 2022

Subject(s):

Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
Cost-Effectiveness Analysis
Genetic Therapy
Hemophilia A -- therapy
Hemophilia B -- therapy
United States

7. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

Author(s):

Tice, Jeffrey A., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Chapman, Rick, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author
Mandrik, Olena, author
Thokala, P. (Praveen), author
Fotheringham, James, (Of University of Sheffield), author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2021

Subject(s):

Antibodies, Monoclonal, Humanized
B-Cell Activating Factor -- antagonists & inhibitors
Calcineurin Inhibitors -- therapeutic use
Cyclosporine -- therapeutic use
Immunosuppressive Agents -- therapeutic use
Lupus Nephritis -- drug therapy
Treatment Outcome
United States

8. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

Author(s):

Lin, Grace A., author
Jih, Jane, author
Agboola, Foluso, author
Peason, Steven D., author
Kazi, Dhruv S., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021

Subject(s):

Anticholesteremic Agents -- therapeutic use
Atherosclerosis -- prevention & control
ATP Citrate (pro-S)-Lyase -- antagonists & inhibitors
Dicarboxylic Acids -- therapeutic use
Fatty Acids
Hyperlipoproteinemia Type II -- drug therapy
RNA, Small Interfering
Secondary Prevention
Treatment Outcome
Drug Therapy, Combination
Ezetimibe -- therapeutic use
United States

9. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

Author(s):

Mustafa, Reem A., author
Fox, Grace, (Of Institute for Clinical and Economic Review), author
Campbell, Jonathan D., author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Bloudek, Lisa, author
Carlson, Josh J., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 5, 2021

Subject(s):

Glycine -- analogs & derivatives
Hematinics -- therapeutic use
Isoquinolines -- therapeutic use
Hypoxia-Inducible Factor-Proline Dioxygenases -- antagonists & inhibitors
Anemia, Iron-Deficiency -- drug therapy
Renal Insufficiency, Chronic -- complications
Renal Insufficiency, Chronic -- drug therapy
Treatment Outcome
United States

10. Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report

Author(s):

Rind, David M., author
Walton, Surrey M., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Quach, Danny, author
Chapman, Rick M., author
Pearson, Steven D., author
Bradt, Pamela, author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 20, 2020

Subject(s):

Antibodies, Monoclonal
Genetic Therapy
Hemophilia A -- drug therapy
United States

11. Eculizumab and efgartigimod for the treatment of myasthenia gravis: effectiveness and value : final report

Author(s):

Tice, Jeffrey A., author
Touchette, Daniel R., author
Nikitin, Dmitriy, author
Campbell, Jon, author
Lien, Pei-Wen, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Agboola, Foluso, author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021

Subject(s):

Immunosuppressive Agents
Myasthenia Gravis -- drug therapy
United States

12. Esketamine for the treatment of treatment-resistant depression: effectiveness and value : final evidence report

Author(s):

Atlas, Steven, author
Agboola, Foluso, author
Fazioli, Katherine, author
Fluetsch, Noemi, author
Kumar, Varun, author
O'Grady, Madeline, author
Rind, David, author
Pearson, Steve, author
Touchette, Daniel R., author
Boyer, Nicole, author
Talon, Brian, author
Schultz, Bob G., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019

Subject(s):

Depressive Disorder, Treatment-Resistant -- drug therapy
Hallucinogens -- therapeutic use
United States